Nanoform Finland Oyj (HEL:NANOFH)

Finland flag Finland · Delayed Price · Currency is EUR
0.667
-0.054 (-7.49%)
Mar 3, 2026, 12:57 PM EET
-42.30%
Market Cap 61.67M
Revenue (ttm) 5.02M
Net Income (ttm) -17.90M
Shares Out 85.53M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 238,207
Average Volume 184,310
Open 0.719
Previous Close 0.721
Day's Range 0.661 - 0.719
52-Week Range 0.667 - 1.382
Beta 0.31
RSI 24.54
Earnings Date Feb 26, 2026

About Nanoform Finland Oyj

Nanoform Finland Oyj engages in the provision of nanotechnology and drug particle engineering services for the pharma and biotech industries in Europe and the United States. The company provides nanoforming technologies, formulation, and analytical services, including controlled expansion of supercritical solutions technology that enables the creation of active pharmaceutical ingredients (API) nanoparticles directly from solution; biological nanoforming technology; and flexible dosage forms of nanoformed drug substances. It also offers STARMAP,... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 173
Stock Exchange Nasdaq Helsinki
Ticker Symbol NANOFH
Full Company Profile

Financial Performance

In 2025, Nanoform Finland Oyj's revenue was 5.02 million, an increase of 37.10% compared to the previous year's 3.66 million. Losses were -17.90 million, -23.60% less than in 2024.

Financial Statements

News

Nanoform Finland PLC (FRA:4YL) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ...

Nanoform Finland PLC (FRA:4YL) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Expansion Drive Growth

3 days ago - GuruFocus

Q4 2025 Nanoform Finland Oyj Earnings Call Transcript

Q4 2025 Nanoform Finland Oyj Earnings Call Transcript

3 days ago - GuruFocus

Nanoform Finland Oyj: Inside information: Nanoform starts change negotiations as part of announced new midterm business targets for 2030

Nanoform Finland Plc | Inside Information | January 07, 2026 at 08:05:00 EET Helsinki, Finland - Nanoform Finland Plc ("Nanoform") starts change negotiations in accordance with the Act on Cooperati...

7 weeks ago - Finanz Nachrichten

Nanoform Finland Oyj: Inside information: Nanoform announces new midterm business targets for 2030

Nanoform Finland Plc | Inside Information | December 16, 2025 at 07:00:00 EET Helsinki, Finland - Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company, today announced new ...

2 months ago - Finanz Nachrichten

Nanoform Finland PLC (FRA:4YL) Q3 2025 Earnings Call Highlights: Strong Cash Flow and Strategic ...

Nanoform Finland PLC (FRA:4YL) Q3 2025 Earnings Call Highlights: Strong Cash Flow and Strategic Growth Amid Market Challenges

3 months ago - GuruFocus

Q3 2025 Nanoform Finland Oyj Earnings Call Transcript

Q3 2025 Nanoform Finland Oyj Earnings Call Transcript

3 months ago - GuruFocus

Nanoform Finland PLC (FRA:4YL) Q3 2024 Earnings Call Highlights: Record Deals and Improved ...

Nanoform Finland PLC (FRA:4YL) Q3 2024 Earnings Call Highlights: Record Deals and Improved Margins Signal Growth

1 year ago - GuruFocus

Q3 2024 Nanoform Finland Oyj Earnings Call Transcript

Q3 2024 Nanoform Finland Oyj Earnings Call Transcript

1 year ago - GuruFocus